• Annual Meeting Highlights of ASCO 2018 in Pancreatic Cancer
  • Your Patient is Diagnosed with Metastatic Pancreatic Cancer: Do You Know the Best Treatment Options?
  • The Current State of Personalized Medicine: Biomarkers in Pancreatic Cancer
  • MediCom Oncology Clinical Pearls Podcasts

What's New

CE Education
Clinical Trial Tracker: An Update on Promising Phase 2 and 3 Clinical Trials in Pancreatic Cancer
J. Randolph Hecht, MD
Knowledge Library
What is the best sequencing approach for second-line therapy when using FOLFIRINOX in the first line?
Tanios Bekaii-Saab, MD, FACP
Clinical Expert Commentary
One Major Healthcare System’s Approach to Standardized Care Pathways for the Treatment of Pancreatic Cancer
Federico A. Sanchez, MD
CE Education
Annual Meeting Highlights of ASCO 2018 in Pancreatic Cancer
J. Randolph Hecht, MD; Eileen M. O’Reilly, MD; Emanuel F. Petricoin III, PhD; Vincent Picozzi, Jr., MD, MMM; Federico A. Sanchez, MD; Andrea Wang-Gillam, MD, PhD
Knowledge Library
What is the future role of maintenance therapy in pancreatic cancer?
Vincent Picozzi, Jr., MD, MMM
CE Education
Your Patient is Diagnosed with Metastatic Pancreatic Cancer: Do You Know the Best Treatment Options?
Tanios Bekaii-Saab, MD, FACP
CE Education
The Current State of Personalized Medicine: Biomarkers in Pancreatic Cancer
Eileen M. O’Reilly, MD
Clinical Pearls Podcasts
Listen or download these brief audio clips to use at the point of care in your practice!